Skip to main content
DOI:
10.1055/s-00034924
Nuklearmedizin - NuclearMedicine
Issue 01 ·
Volume 38 ·
1999
DOI: 10.1055/s-008-37993
Originalarbeiten — Original Articles
1
Börner, Anne-Rose;
Voth, E.;
Wienhard, K.;
Wagner, R.;
Schicha, H.:
F-18-FDG-PET in Autonomous Goiter
7
Dietlein, M.;
Moka, D.;
Dederichs, Birgit;
Hunsche, Elke;
Lauterbach, K. W.;
Schicha, H.:
Cost-effectiveness-analysis: Radioiodine or Antithyroid Drugs as First-line Therapy of Hyperthyroidism due to Graves’ Disease
15
Görges, R.;
Kahaly, G.;
Müller-Brand, J.;
Mäcke, H.;
Walgenbach, S.;
Bruns, C.;
Andreas, J.;
Brandt-Mainz, K.;
Bockisch, A.:
Examination of the Somatostatin Receptor Status in Non-medullary Thyroid Cancer
24
Cremerius, U.;
Fabry, U.;
Kröll, U.;
Zimny, M.;
Neuerburg, J.;
Osieka, R.;
Büll, U.:
Clinical Value of FDG-PET for Therapy Monitoring of Malignant Lymphoma – Results of a Retrospective Study in 72 Patients
31
Reinartz, P.;
Sabri, O.;
Kinzel, S.;
Zimny, M.;
Bachmann, T.;
Küpper, W.;
Büll, U.:
Radioiodine Therapy in Veterinary Medicine: Treatment of Hyperthyroidism in a Cat
35
Mikosch, P.;
Gallowitsch, H. J.;
Kresnik, E.;
Lind, P.:
Thyroid Hemiagenesis with Immunthyropathy
